The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
12 Years and older (Child, Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients must have:
HIV-seropositivity confirmed by Western Blot.
- AZT for study patients.
Patients with the following symptoms and conditions are excluded:
Hospitalization for opportunistic infection, bacterial infection or malignancy.
AZT (for control group).
Antibiotics or other medication for opportunistic infection, bacterial infection, or malignancy.
Patients with the following prior conditions are excluded:
Hospitalization for opportunistic infection, bacterial infection, or malignancy.
AZT 1-2 gm daily (for study patient) or not taking AZT (for control).